[1]吴梅梅,王靖雯,魏丽丽,等.原发性肝细胞性肝癌患者术后癌旁组织CXCR4表达的影响因素与术后生存时间[J].福建医药杂志,2023,45(02):8-11.
　WU Meimei,WANG Jingwen,WEI Lili,et al.Study on the influencing factors of CXCR4 expression in paracancerous tissue and postoperative survival time in patients with primary hepatocellular carcinoma after surgery[J].FUJIAN MEDICAL JOURNAL,2023,45(02):8-11.
点击复制

原发性肝细胞性肝癌患者术后癌旁组织CXCR4表达的影响因素与术后生存时间()
分享到：

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
45
期数:
2023年02期
页码:
8-11
栏目:
临床研究
出版日期:
2023-04-15

文章信息/Info

Title:
Study on the influencing factors of CXCR4 expression in paracancerous tissue and postoperative survival time in patients with primary hepatocellular carcinoma after surgery
文章编号:
1002-2600(2023)02-0008-04
作者:
吴梅梅; 王靖雯; 魏丽丽; 黄富妹; 黄警; 郑益武; 朱琪1
福建省福州市第二医院感控科（福州 350007）
Author(s):
WU Meimei;  WANG Jingwen;  WEI Lili;  HUANG Fumei;  HUANG Jing;  ZHENG Yiwu;  ZHU Qi
Department of Infection Control, Fuzhou Municipal Second Hospital，Fuzhou，Fujian 350007，China
关键词:
原发性肝癌; 癌旁组织; CXCR4; 生存期
Keywords:
primary hepatocellular carcinoma;  paracancerous tissue;  CXCR4;  survival
分类号:
R735.7
文献标志码:
B
摘要:
目的 探究原发性肝细胞性肝癌患者术后癌旁组织中CXCR4表达情况的影响因素与术后生存时间。方法收集34例原发性肝细胞性肝癌手术病例的一般情况及临床特征并进行定期随访。使用免疫组织化学法检测原发性肝细胞性肝癌患者的癌组织及癌旁组织中CXCR4的表达情况。比较癌旁组织CXCR4不同表达时的一般情况及临床指征；利用Kaplan-Meier法绘制生存曲线，Log-rank检验进行不同癌旁组织CXCR4表达的术后生存率的比较。结果 随访截至2022年6月，19例癌旁组织CXCR4阳性表达患者中死亡8例，17例癌旁组织CXCR4阴性表达患者中死亡1例。有HBsAg携带、Child分级B级以及有饮酒史的肝癌患者，术后癌旁组织中CXCR4的阳性表达率较高，差异均有统计学意义（P<0.05）。癌旁组织CXCR4阳性患者术后生存率低于阴性患者（Log-rank χ2=5.89，P=0.015）。结论 术后癌旁组织CXCR4的表达情况对原发性肝细胞性肝癌术后患者的预后有影响。
Abstract:
Objective To investigate the influencing factors of CXCR4 expression in paracancerous tissue and postoperative survival time in patients with primary hepatocellular carcinoma after surgery. Methods The general information and clinical characteristics of 34 cases of primary hepatocellular carcinoma were collected and followed up regularly. The expression of CXCR4 in cancer and paracancerous tissues of patients with primary hepatocellular carcinoma was detected by immunohistochemical method. The patients were divided into two groups according to different expression of CXCR4 in paracancerous tissues. Survival rates were calculated by using the Kaplan-Meier method and compared by using the Log-rank test. Results The follow-up ended in June 2022. Eight of the 19 patients with positive CXCR4 expression in paracancerous tissues died, and one of the 17 patients with CXCR4 negative expression in paracancerous tissues died. Patients with HBsAg carriage, Child grade B, and a history of alcohol consumption had higher positive expression of CXCR4 in postoperative paracancerous tissues, and all these differences were statistically significant (P<0.05). The survival rate of patients with positive CXCR4 expression in paracancerous tissues was lower than that of patients with negative CXCR4 expression (Log-rank χ2=5.89, P=0.015）. Conclusion The expression of CXCR4 in paracancerous tissue has an impact on the prognosis of patients with primary hepatocellular carcinoma after surgery.

参考文献/References:

[1] Sung H,Ferlay J,Siegel R L,et al.Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA：A Cancer Journal for Clinicians,2021,70（4）：313.
[2] 马莉,杨文娟,马青梅,等.CXCL家族作为肝癌微环境预后与治疗标志物的生物信息学分析[J].暨南大学学报：自然科学与医学版,2022,43（1）：29-42.
[3] 张敏,张红河,来茂德.肿瘤免疫编辑中肿瘤微环境的变化[J].中华病理学杂志,2021,50（9）：1098-1102.
[4] Nagarsheth N,Wicha M S,Zou W.Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy[J].Nat Rev Immunol,2017,17（9）：559-572.
[5] Bhoori S,Mazzaferro V.Combined immunotherapy and VEGF-antagonist in hepatocellular carcinoma：a step forward[J].The Lancet Oncology,2020,21（6）：740-741.
[6] 徐鸣,全培青,王秋梅,等.血清CXCL12及其受体CXCR4,CXCR7水平对宫颈癌复发的预测价值[J].检验医学与临床,2022,19（8）：1065-1069.
[7] Liu P,Ping L,Yu H,et al.CXCL12/CXCR4 axis induces proliferation and invasion in human endometrial cancer[J].Am J Transl Res,2016,8（4）：1719-1729.
[8] Gao P T,Ding G Y,Yang X,et al.Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4[J].Am J Cancer Res,2018,8（6）：1040-1049.
[9] 孙牧男,刘磊,马寅芙,等.CXCL12/CXCR4在小细胞肺癌患者中的表达及临床意义[J].中国实验诊断学,2015,19（1）：50-53.
[10] 王森,落继先,Istvan Boldogh.CXCL12-CXCR4在人类恶性肿瘤中的生物学功能（英文）[J].中国生物化学与分子生物学报,2022,8（5）：577-586.
[11] 谢永丽,汤华.YTHDF1对HBV蛋白表达和HBsAg和HBeAg抗原分泌的作用[J].天津医科大学学报,2021,27（5）：461-466.
[12] 孙冬雪,杨柱,龙奉玺,等.基于酒伤理论探讨肝癌癌前病变中医治疗[J].辽宁中医药大学学报,2020,22（6）：56-60.
[13] Byrne S,Boyle T,Ahmed M,et al.Lifestyle,genetic risk and incidence of cancer：a prospective cohort study of 13 cancer types[J].Int J Epidemiol,2023：dyac238.
[14] 蒋建强.术前Child分级、微血管侵犯与原发性肝癌同种异体肝移植患者预后的相关性[J].中国卫生工程学,2020,19（5）：775-776.
[15] Chatterjee S,Azad B B,Nimmagadda S.The intricate role of CXCR4 in cancer[J].Adv Cancer Res,2014,124：31-82.
[16] Alsayed R K M E,Khan A Q,Ahmad F,et al.Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression[J].Semin Cancer Biol,2022,86（Pt 2）：697-708.
[17] 唐超莉.CXCR4表达与三阴性乳腺癌的相关性研究[J].中国当代医药,2020,27（19）：118-121.
[18] Moreno M J,Bosch R,Dieguez-Gonzalez R,等.CXCR4表达可增强弥漫大B细胞淋巴瘤的播散能力并降低患者生存期[J].临床与实验病理学杂志,2015,31（10）：1122.
[19] 唐文龙.CXCL12/CXCR4在胶质瘤中的表达情况及其与复发、瘤周水肿的关系[D].福州：福建医科大学,2016.

相似文献/References:

[1]杨蔡江.胃癌癌组织中p27与cyclinD1的表达及临床意义[J].福建医药杂志,2017,39(5):50.

备注/Memo

备注/Memo:
1 通信作者，Email:86986281@qq.com
更新日期/Last Update: 2023-04-15